BLD-2660

Blade Therapeutics updates enrollment progress for Covid-19 pneumonia study of BLD-2660
Pharmaceutical Business Review
Thu, 08/13/20 - 09:49 am
Blade Therapeutics
clinical trials
BLD-2660
COVID-19
COVID-19 pneumonia